BackStatera BioPharma Overview
Statera BioPharma Inc

Statera BioPharma Return on Equity

Latest ROE for Statera BioPharma: 1018.79% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

1018.79%

Return on Equity

1018.79%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Statera BioPharma (STAB) FAQ

As of the most recent data, STAB shows a ROE of 1018.79%. That is above the Healthcare sector average of 13.1%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average ROE is about 13.1%. Statera BioPharma is at 1018.79%, which is higher that average. That is roughly 7674.8% above the sector mean. Use the comparison chart on this page to see how STAB stacks up against individual peers as well.

Check the historical chart to see whether STAB's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Statera BioPharma with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Statera BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 1018.79%) with ownership activity and broader fundamentals.

The Healthcare average ROE is about 13.1%, while STAB is at 1018.79%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.